A citation-based method for searching scientific literature

I E Smith, A L Jones, M E O'Brien, J A McKinna, N Sacks, M Baum. Eur J Cancer 1993
Times Cited: 79







List of co-cited articles
325 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6.
S M Scholl, A Fourquet, B Asselain, J Y Pierga, J R Vilcoq, J C Durand, T Dorval, T Palangié, M Jouve, P Beuzeboc. Eur J Cancer 1994
333
49

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.
G Bonadonna, U Veronesi, C Brambilla, L Ferrari, A Luini, M Greco, C Bartoli, G Coopmans de Yoldi, R Zucali, F Rilke. J Natl Cancer Inst 1990
495
43

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer.
C Jacquillat, M Weil, F Baillet, C Borel, G Auclerc, M A de Maublanc, M Housset, G Forget, L Thill, C Soubrane. Cancer 1990
198
39

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.
T J Powles, T F Hickish, A Makris, S E Ashley, M E O'Brien, V A Tidy, S Casey, A G Nash, N Sacks, D Cosgrove. J Clin Oncol 1995
281
37

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
B Fisher, J Bryant, N Wolmark, E Mamounas, A Brown, E R Fisher, D L Wickerham, M Begovic, A DeCillis, A Robidoux,[...]. J Clin Oncol 1998
35


Neoadjuvant chemotherapy in 126 operable breast cancers.
E Bélembaogo, V Feillel, P Chollet, H Curé, P Verrelle, F Kwiatkowski, J L Achard, G Le Bouëdec, J Chassagne, Y J Bignon. Eur J Cancer 1992
78
30

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.
B Fisher, A Brown, E Mamounas, S Wieand, A Robidoux, R G Margolese, A B Cruz, E R Fisher, D L Wickerham, N Wolmark,[...]. J Clin Oncol 1997
30

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.
I E Smith, G Walsh, A Jones, J Prendiville, S Johnston, B Gusterson, F Ramage, H Robertshaw, N Sacks, S Ebbs. J Clin Oncol 1995
165
27

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.
G N Hortobagyi, F C Ames, A U Buzdar, S W Kau, M D McNeese, D Paulus, V Hug, F A Holmes, M M Romsdahl, G Fraschini. Cancer 1988
382
27

Primary systemic therapy for operable breast cancer.
E D Anderson, A P Forrest, R A Hawkins, T J Anderson, R C Leonard, U Chetty. Br J Cancer 1991
66
31

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
G Bonadonna, P Valagussa, C Brambilla, L Ferrari, A Moliterni, M Terenziani, M Zambetti. J Clin Oncol 1998
440
25

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.
H M Kuerer, L A Newman, T L Smith, F C Ames, K K Hunt, K Dhingra, R L Theriault, G Singh, S M Binkley, N Sneige,[...]. J Clin Oncol 1999
22

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer.
A Makris, T J Powles, S E Ashley, J Chang, T Hickish, V A Tidy, A G Nash, H T Ford. Ann Oncol 1998
249
21


Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer.
V F Semiglazov, E E Topuzov, J L Bavli, V M Moiseyenko, O A Ivanova, I K Seleznev, A A Orlov, N Y Barash, O M Golubeva, O F Chepic. Ann Oncol 1994
159
18



Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.
S M Swain, R A Sorace, C S Bagley, D N Danforth, J Bader, M N Wesley, S M Steinberg, M E Lippman. Cancer Res 1987
233
16

Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
G Calais, C Berger, P Descamps, S Chapet, A Reynaud-Bougnoux, G Body, P Bougnoux, J Lansac, O Le Floch. Cancer 1994
111
16

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival.
S M Scholl, J Y Pierga, B Asselain, P Beuzeboc, T Dorval, E Garcia-Giralt, M Jouve, T Palangié, Y Remvikos, J C Durand. Eur J Cancer 1995
127
16


Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery.
M De Lena, M Varini, R Zucali, D Rovini, G Viganotti, P Valagussa, U Veronesi, G Bonadonna. Cancer Clin Trials 1981
184
16


Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast.
G F Schwartz, C A Birchansky, L T Komarnicky, C M Mansfield, R I Cantor, W A Biermann, F M Fellin, J McFarlane. Cancer 1994
193
15


A human tumour model.
A P Forrest, P A Levack, U Chetty, R A Hawkins, W R Miller, J F Smyth, T J Anderson. Lancet 1986
72
15

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.
J A van der Hage, C J van de Velde, J P Julien, M Tubiana-Hulin, C Vandervelden, L Duchateau. J Clin Oncol 2001
749
13

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.
B Fisher, C Redmond, R Poisson, R Margolese, N Wolmark, L Wickerham, E Fisher, M Deutsch, R Caplan, Y Pilch. N Engl J Med 1989
12

Conservation surgery after primary chemotherapy in large carcinomas of the breast.
U Veronesi, G Bonadonna, S Zurrida, V Galimberti, M Greco, C Brambilla, A Luini, S Andreola, F Rilke, R Raselli. Ann Surg 1995
126
12

Presence of a growth-stimulating factor in serum following primary tumor removal in mice.
B Fisher, N Gunduz, J Coyle, C Rudock, E Saffer. Cancer Res 1989
317
12


Multimodal treatment of locoregionally advanced breast cancer.
G N Hortobagyi, G R Blumenschein, W Spanos, E D Montague, A U Buzdar, H Y Yap, F Schell. Cancer 1983
197
12


Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.
A U Buzdar, S E Singletary, R L Theriault, D J Booser, V Valero, N Ibrahim, T L Smith, L Asmar, D Frye, N Manuel,[...]. J Clin Oncol 1999
188
10

Reporting results of cancer treatment.
A B Miller, B Hoogstraten, M Staquet, A Winkler. Cancer 1981
10

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
Harry D Bear, Stewart Anderson, Ann Brown, Roy Smith, Eleftherios P Mamounas, Bernard Fisher, Richard Margolese, Heather Theoret, Atilla Soran, D Lawrence Wickerham,[...]. J Clin Oncol 2003
794
10

Pathological assessment of response to induction chemotherapy in breast cancer.
L D Feldman, G N Hortobagyi, A U Buzdar, F C Ames, G R Blumenschein. Cancer Res 1986
313
8




Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy.
P Valagussa, M Zambetti, G Bonadonna, R Zucali, G Mezzanotte, U Veronesi. Breast Cancer Res Treat 1990
99
8

CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY.
C D Haagensen, A P Stout. Ann Surg 1943
215
8

Clinical and pathological response to primary chemotherapy in operable breast cancer.
P Chollet, S Charrier, E Brain, H Curé, I van Praagh, V Feillel, M de Latour, J Dauplat, J L Misset, J P Ferrière. Eur J Cancer 1997
89
8

Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study.
M Perloff, G J Lesnick, A Korzun, F Chu, J F Holland, M P Thirlwell, R R Ellison, R W Carey, L Leone, V Weinberg. J Clin Oncol 1988
145
8

Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer.
M De Lena, R Zucali, G Viganotti, P Valagussa, G Bonadonna. Cancer Chemother Pharmacol 1978
231
8

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel.
Ian C Smith, Steven D Heys, Andrew W Hutcheon, Iain D Miller, Simon Payne, Fiona J Gilbert, Antoinne K Ah-See, Oleg Eremin, Leslie G Walker, Tarun K Sarkar,[...]. J Clin Oncol 2002
552
8

Primary chemotherapy in surgically resectable breast cancer.
G Bonadonna, P Valagussa, R Zucali, B Salvadori. CA Cancer J Clin 1995
83
8

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.
P Ellis, I Smith, S Ashley, G Walsh, S Ebbs, M Baum, N Sacks, J McKinna. J Clin Oncol 1998
100
7

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.
H M Kuerer, L A Newman, A U Buzdar, K K Hunt, K Dhingra, T A Buchholz, S M Binkley, F C Ames, B W Feig, M I Ross,[...]. Am J Surg 1998
121
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.